Invention Application
- Patent Title: SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
-
Application No.: US17303955Application Date: 2021-06-10
-
Publication No.: US20220362259A1Publication Date: 2022-11-17
- Inventor: Xifu LIANG , Jens LARSEN , Simon Feldbaek NIELSEN , Peter ANDERSEN
- Applicant: LEO Pharma A/S
- Applicant Address: DK Ballerup
- Assignee: LEO Pharma A/S
- Current Assignee: LEO Pharma A/S
- Current Assignee Address: DK Ballerup
- Priority: EP16203335.1 20161212
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D491/20
Abstract:
The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
Information query
